Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.

Literature DB >> 2670296

Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.

Abstract

This Memorandum reviews the present status of allergen immunotherapy, its scientific basis, and the clinical evidence of its efficacy. It also makes recommendations on both indications and contraindications, the most appropriate allergens and treatment regimens, and on prevention and management of adverse reactions. Finally, it indicates future developments in this form of treatment.

Mesh：

Substances：

Year: 1989 PMID： 2670296 PMCID： PMC2491247

Source DB: PubMed Journal: Bull World Health Organ ISSN： 0042-9686 Impact factor: 9.408

39 in total

1. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects.

Authors: M F D'Souza; J Pepys; I D Wells; E Tai; F Palmer; B G Overell; I T McGrath; M Megson
Journal: Clin Allergy Date: 1973-06

2. The potency and Group I antigen content of six commercially prepared grass pollen extracts.

Authors: H Baer; C J Maloney; P S Norman; D G Marsh
Journal: J Allergy Clin Immunol Date: 1974-09 Impact factor: 10.793

3. Generation of antigen-specific suppressor cells during allergy desensitization.

Authors: R E Rocklin; A L Sheffer; D K Greineder; K L Melmon
Journal: N Engl J Med Date: 1980-05-29 Impact factor: 91.245

4. Onset of polyarteritis nodosa during allergic hyposensitization treatment.

Authors: P Phanuphak; P F Kohler
Journal: Am J Med Date: 1980-04 Impact factor: 4.965

Review 5. IgE class-specific suppressor T cells and regulation of the IgE response.

Authors: T Kishimoto
Journal: Prog Allergy Date: 1982

6. Measurement of the potency of allergy extracts by their inhibitory capacities in the radioallergosorbent test.

Authors: G J Gleich; J B Larson; R T Jones; H Baer
Journal: J Allergy Clin Immunol Date: 1974-03 Impact factor: 10.793

7. Antibody response following prolonged hyposensitization with Dermatophagoides pteronyssinus extract.

Authors: M D Chapman; T A Platts-Mills; M Gabriel; H K Ng; W G Allan; L E Hill; A J Nunn
Journal: Int Arch Allergy Appl Immunol Date: 1980

8. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before dextran 70 or dextran 40.

Authors: K G Ljungström; H Renck; H Hedin; W Richter; B Rosberg
Journal: Acta Chir Scand Date: 1983

9. Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E.

Authors: A Saxon; C Morrow; R H Stevens
Journal: J Clin Invest Date: 1980-06 Impact factor: 14.808

10. A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results.

Authors: P C Turkeltaub; S C Rastogi; H Baer; M C Anderson; P S Norman
Journal: J Allergy Clin Immunol Date: 1982-11 Impact factor: 10.793

2 in total

1. Isotype-selective abrogation of established IgE responses.

Authors: K T HayGlass; W Stefura
Journal: Clin Exp Immunol Date: 1990-12 Impact factor: 4.330

2. Long-lived reciprocal regulation of antigen-specific IgE and IgG2a responses in mice treated with glutaraldehyde-polymerized ovalbumin.

Authors: K T Hayglass; R S Gieni; W P Stefura
Journal: Immunology Date: 1991-08 Impact factor: 7.397

2 in total